These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 4692254)

  • 1. Inheritance of type 2 Crigler-Najjar hyperbilirubinaemia.
    Hunter JO; Thompson RP; Dunn PM; Williams R
    Gut; 1973 Jan; 14(1):46-9. PubMed ID: 4692254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crigler-Najjar type II disease inheritance: a family study.
    Labrune P; Myara A; Hennion C; Gout JP; Trivin F; Odievre M
    J Inherit Metab Dis; 1989; 12(3):302-6. PubMed ID: 2515370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Controlled trial of phetharbital, a non-hypnotic barbiturate, in unconugated hyperbilirubinaemia.
    Hunter J; Thompson RP; Rake MO; Williams R
    Br Med J; 1971 May; 2(5760):497-9. PubMed ID: 4931488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bile bilirubin pigment analysis in disorders of bilirubin metabolism in early infancy.
    Lee WS; McKiernan PJ; Beath SV; Preece MA; Baty D; Kelly DA; Burchell B; Clarke DJ
    Arch Dis Child; 2001 Jul; 85(1):38-42. PubMed ID: 11420196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The differential diagnosis of Crigler-Najjar disease, types 1 and 2, by bile pigment analysis.
    Sinaasappel M; Jansen PL
    Gastroenterology; 1991 Mar; 100(3):783-9. PubMed ID: 1993500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapeutic use of Luminal in Crigler-Najjar type icterus].
    Rubino A; Barbieri A; Pierro M
    Pediatria (Napoli); 1968 Jun; 76(3):358-65. PubMed ID: 5740396
    [No Abstract]   [Full Text] [Related]  

  • 7. [Phenobarbital therapy in congenital nonhemolytic hyperbilirubinemia (Crigler-Najjar)--report of 5 cases].
    Schellong G; Soennecken U
    Monatsschr Kinderheilkd (1902); 1971 Jul; 119(7):422-4. PubMed ID: 5093938
    [No Abstract]   [Full Text] [Related]  

  • 8. Genetic lesions of bilirubin uridine-diphosphoglucuronate glucuronosyltransferase (UGT1A1) causing Crigler-Najjar and Gilbert syndromes: correlation of genotype to phenotype.
    Kadakol A; Ghosh SS; Sappal BS; Sharma G; Chowdhury JR; Chowdhury NR
    Hum Mutat; 2000 Oct; 16(4):297-306. PubMed ID: 11013440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolonged survival in three brothers with severe type 2 Crigler-Najjar syndrome. Ultrastructural and metabolic studies.
    Gollan JL; Huang SN; Billing B; Sherlock S
    Gastroenterology; 1975 Jun; 68(6):1543-55. PubMed ID: 805737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical and biochemical studies in the Crigler-Najjar syndrome].
    Kline W; Rosenkranz A
    Monatsschr Kinderheilkd (1902); 1971 Oct; 119(10):555-8. PubMed ID: 5116339
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of phenobarbitone on plasma (14C)bilirubin clearance in patients with unconjugated hyperbilirubinaemia.
    Black M; Fevery J; Parker D; Jacobson J; Billing BH; Carson ER
    Clin Sci Mol Med; 1974 Jan; 46(1):1-17. PubMed ID: 4204548
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of treatments for congenital nonobstructive nonhaemolytic hyperbilirubinaemia.
    Arrowsmith WA; Payne RB; Littlewood JM
    Arch Dis Child; 1975 Mar; 50(3):197-201. PubMed ID: 1147651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crigler-Najjar Syndrome Type II Diagnosed in a Patient with Jaundice Since Birth.
    Liaqat A; Shahid A; Attiq H; Ameer A; Imran M
    J Coll Physicians Surg Pak; 2018 Oct; 28(10):806-808. PubMed ID: 30266131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unconjugated bilirubin and an increased proportion of bilirubin monoconjugates in the bile of patients with Gilbert's syndrome and Crigler-Najjar disease.
    Fevery J; Blanckaert N; Heirwegh KP; Préaux AM; Berthelot P
    J Clin Invest; 1977 Nov; 60(5):970-9. PubMed ID: 409736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacologic treatment of a case of Crigler-Najjar syndrome].
    Lupi L; Di Tullio MT
    Pathologica; 1972; 64(931):223-6. PubMed ID: 4671380
    [No Abstract]   [Full Text] [Related]  

  • 16. Persistent jaundice in an infant with homozygous beta thalassemia due to co-inherited Crigler-Najjar syndrome.
    Aggarwal V; Seth A; Sharma S; Aneja S; Sammarco P; Fabiano C
    Pediatr Blood Cancer; 2010 Apr; 54(4):627-8. PubMed ID: 19953640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crigler-Najjar syndrome types I and II. Clinical experience--King's College Hospital 1972-1978. Phenobarbitone, phototherapy and liver transplantation.
    Pett S; Mowat AP
    Mol Aspects Med; 1987; 9(5):473-82. PubMed ID: 3306242
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of phenobarbital on serum and biliary parameters in a patient with Crigler-Najjar syndrome, type II and acquired cholestasis.
    Trotman BW; Shaw L; Roy-Chowdhury J; Malet PF; Rosato EF
    Dig Dis Sci; 1983 Aug; 28(8):753-62. PubMed ID: 6872808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular pathology of Crigler-Najjar type I and II and Gilbert's syndromes.
    Sampietro M; Iolascon A
    Haematologica; 1999 Feb; 84(2):150-7. PubMed ID: 10091414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Gilbert's jaundice. Current clinico-nosographic physiopathological and therapeutical aspects. I. Recent findings in Gilbert's syndrome].
    Lovisetto P; Giorcelli W; Actis GC; Biarese V
    Minerva Med; 1976 Jul; 67(35):2253-65. PubMed ID: 821019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.